Pharmaceutical Industry Information Portal

HomeTop

Top

Australian Biotron’s share price rose 38% due to COVID-19 study results

Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today. Biotron Limited is engaged in the...

Biogen withdraws application for Alzheimer’s disease drug in Europe

Biogen Inc. has notified the European Medicines Agency (EMA) of its decision to withdraw its Marketing Authorization Application (MAA) for aducanumab for the treatment...

Reify Health raises $220 million to increase diversity in clinical trial participation

Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D round co-led by Altimeter Capital and...

Halozyme to acquire Antares Pharma in a $960 million deal

Halozyme Therapeutics, Inc. and Antares Pharma, Inc. announced that the companies have entered into a definitive agreement pursuant to which Halozyme will acquire Antares...

Omicron-specific vaccine candidates containing inactivated or “killed” coronaviruses approved for clinical trials

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong,...

Oulu University Hospital has signed a strategic partnership with Philips to become “the smartest hospital in the world”

Royal Philips, a global leader in health technology, and Oulu University Hospital in Finland Apr 11th announced a strategic 10-year partnership agreement to support...
spot_img

Expert Articles

spot_img